Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.
FDMT4 quarters
Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in 4D MOLECULAR THERAPEUTICS IN
ADAGE CAPITAL PARTNERS GP, L.L.C. holds 2.2M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $29.9M as of 2026-Q2. The position was increased (+40.1% shares). FDMT represents 0.0% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.
Current Value
$29.9M
Current Shares
2.2M
Total Value Change
+$28.4M
Total Shares Change
+2.1M
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.